Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Ivan

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Cancer Research|January 23, 2013
Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancerLianjin Jin, Oliver Wessely, Eric G Marcusson, et al.
Cancer Research|March 8, 2018
Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor NicheSalvatore Condello, Livia Sima, Cristina Ivan, et al.
Aging|June 22, 2021
miRNAs generated from Meg3-Mirg locus are downregulated during agingAna-Mihaela Lupan, Evelyn-Gabriela Rusu, Mihai Bogdan Preda, et al.
Cancers|July 24, 2021
Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast CancerDebaditya Chakraborty, Cristina Ivan, Paola Amero, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2015
Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axisHyun Ho Choi, Sergei Guma, Lekun Fang, et al.
Neoplasia (New York, N.Y.)|October 30, 2016
Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic CancerJiyoon Lee, Bakhtiyor Yakubov, Cristina Ivan, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancerLivia Elena Sima, Siqi Chen, Horacio Cardenas, et al.
Oncogene|November 21, 2018
EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesisJingnan An, Yi Du, Xuejun Fan, et al.
Cancer Letters|May 11, 2018
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretionBharat K R Chaganty, Songbo Qiu, Anneliese Gest, et al.
BMC Cancer|January 13, 2017
MALAT1 promoted invasiveness of gastric adenocarcinomaNa Keum Lee, Jung Hwa Lee, Cristina Ivan, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Cancer Research|January 23, 2013
Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancerLianjin Jin, Oliver Wessely, Eric G Marcusson, et al.
Cancer Research|March 8, 2018
Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor NicheSalvatore Condello, Livia Sima, Cristina Ivan, et al.
Aging|June 22, 2021
miRNAs generated from Meg3-Mirg locus are downregulated during agingAna-Mihaela Lupan, Evelyn-Gabriela Rusu, Mihai Bogdan Preda, et al.
Cancers|July 24, 2021
Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast CancerDebaditya Chakraborty, Cristina Ivan, Paola Amero, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2015
Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axisHyun Ho Choi, Sergei Guma, Lekun Fang, et al.
Neoplasia (New York, N.Y.)|October 30, 2016
Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic CancerJiyoon Lee, Bakhtiyor Yakubov, Cristina Ivan, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancerLivia Elena Sima, Siqi Chen, Horacio Cardenas, et al.
Oncogene|November 21, 2018
EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesisJingnan An, Yi Du, Xuejun Fan, et al.
Cancer Letters|May 11, 2018
Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretionBharat K R Chaganty, Songbo Qiu, Anneliese Gest, et al.
BMC Cancer|January 13, 2017
MALAT1 promoted invasiveness of gastric adenocarcinomaNa Keum Lee, Jung Hwa Lee, Cristina Ivan, et al.
Pageof 19